You have 9 free searches left this month | for more free features.

Urinary Incontinence

Showing 7501 - 7525 of 8,497

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lower Urinary Tract Symptoms in Systemic Sclerosis

Unknown status
  • Urinary Symptoms
  • Systemic Sclerosis
    • Paris, France
    • +3 more
    Oct 23, 2013

    Effect of Somatropin on Growth Hormone Deficient Adults

    Completed
    • Hypopituitarism
    • +2 more
    • Somatropin (rDNA origin)
    • (no location specified)
    Mar 25, 2014

    Hyperphosphatemia Trial in Osaka (Lanthanum Carbonate (Fosrenol, BAY77-1931) Granule, Lanthanum Carbonate (Fosrenol, BAY77-1931)

    Completed
    • Hyperphosphatemia
    • Lanthanum Carbonate (Fosrenol, BAY77-1931) Granule
    • Lanthanum Carbonate (Fosrenol, BAY77-1931) Chewable tablet
    • Osaka, Japan
      (unnamed)
    Jun 20, 2014

    Osteoporosis Trial in Bobigny (hydrolyzed collagen, wheat protein)

    Completed
    • Osteoporosis
    • hydrolyzed collagen
    • wheat protein
    • Bobigny, Seine-saint-denis, France
      CRNH - Centre de Recherche sur Volontaires - Hôpital AVICENNE
    Apr 8, 2014

    Leukemia, Lymphoma, MDS Trial in Atlanta (busulfan, cyclophosphamide, fludarabine phosphate)

    Completed
    • Leukemia
    • +2 more
    • Atlanta, Georgia
      Blood and Marrow Transplant Group of Georgia
    Oct 28, 2013

    Sensitivity and Specificity of NGAL inEmergency Room Population

    Completed
    • Azotemia
    • +3 more
      • New York, New York
      • +2 more
      Feb 7, 2014

      Elevated High-sensitivity C-Reactive Protein (hsCRP) Trial in Worldwide (Rosuvastatin, Placebo)

      Terminated
      • Elevated High-sensitivity C-Reactive Protein (hsCRP)
      • Birmingham, Alabama
      • +858 more
      Feb 6, 2014

      Pulmonary Disease, Chronic Obstructive Trial in Worldwide (tiotropium, )

      Completed
      • Pulmonary Disease, Chronic Obstructive
      • Anniston, Alabama
      • +489 more
      May 15, 2014

      Relapsing Remitting Multiple Sclerosis Trial (Glatiramer Acetate, Placebo, Prednisone)

      Terminated
      • Relapsing Remitting Multiple Sclerosis
      • Glatiramer Acetate
      • +2 more
      • (no location specified)
      Nov 15, 2013

      Growth, Hematology, Hydration, Oxidation, Infection,

      Completed
      • Healthy
        • Guatemala, Quetzaltenango, Guatemala
          Center for Studies of Sensory Impairment Aging and Metabolism
        Jul 28, 2014

        Multiple System Atrophy Trial in Napoli (Lithium Carbonate, Placebo)

        Terminated
        • Multiple System Atrophy
        • Lithium Carbonate
        • Placebo
        • Napoli, Italy
          Dipartimento di Scienze Neurologiche
        Dec 17, 2013

        Pulmonary Disease, Chronic Obstructive Trial in Worldwide (tiotropium 18 mcg, tiotropium 1.25 mcg (2 actuations/day), tiotropium

        Completed
        • Pulmonary Disease, Chronic Obstructive
        • tiotropium 18 mcg
        • +2 more
        • Athens, Alabama
        • +1190 more
        May 20, 2014

        Diabetes, Type 2, Hypoglycemic Agents, Diabetic Blood Glucose Monitoring Trial in Porto Alegre (MET + Vildagliptin Group, MET +

        Unknown status
        • Diabetes Mellitus, Type 2
        • +3 more
        • MET + Vildagliptin Group
        • MET + Glibenclamide Group
        • Porto Alegre, Rio Grande do Sul, Brazil
          Hospital de Clínicas de Porto Alegre Porto Alegre
        May 5, 2014

        Diabetes, Type 2 Trial in Worldwide (Placebo identical to BI 1356 5mg, Placebo identical to Glimepiride 1mg or 2mg or 3mg or 4

        Completed
        • Diabetes Mellitus, Type 2
        • Placebo identical to BI 1356 5mg
        • +3 more
        • Tempe, Arizona
        • +220 more
        Dec 11, 2013

        Lymphoma, Hodgkin Disease, Lymphoma, Non-Hodgkin Trial in United States (PCI-24781)

        Completed
        • Lymphoma
        • +2 more
        • San Francisco, California
        • +7 more
        Feb 27, 2014

        Urinary Tract Infection Trial in Seattle (Nitrofurantoin 100mg twice daily x 5 days, TMP/SMX DS twice daily x 3 days)

        Completed
        • Urinary Tract Infection
        • Nitrofurantoin 100mg twice daily x 5 days
        • TMP/SMX DS twice daily x 3 days
        • Seattle, Washington
          University of WA
        Jun 3, 2014

        Pompe Disease (Late-Onset), Glycogen Storage Disease Type II (GSD-II), Glycogenesis Type II Trial in Worldwide (alglucosidase

        Completed
        • Pompe Disease (Late-Onset)
        • +3 more
        • alglucosidase alfa
        • Anchorage, Alaska
        • +30 more
        Feb 4, 2014

        Prostate Cancer Trial in New Brunswick (licorice root extract, docetaxel)

        Terminated
        • Prostate Cancer
        • New Brunswick, New Jersey
          Cancer Institute of New Jersey
        Nov 15, 2013

        Breast Tumors Trial in Worldwide (Tamoxifen, Exemestane)

        Completed
        • Breast Neoplasms
        • Birmingham, Alabama
        • +379 more
        Apr 21, 2014

        Overactive Detrusor Trial in Limerick (Botulinum toxin injected to bladder body, Botulinum toxin injected into trigone)

        Unknown status
        • Overactive Detrusor
        • Botulinum toxin injected to bladder body
        • Botulinum toxin injected into trigone
        • Limerick, Ireland
          University Hospital of Limerick
        Dec 8, 2013

        Benign Prostatic Hyperplasia (BPH) Trial in Worldwide (Permixon® 160 mg, Tamsulosine Arrow LP, Placebo matching Permixon® 160

        Completed
        • Benign Prostatic Hyperplasia (BPH)
        • Permixon® 160 mg
        • +3 more
        • Angers, France
        • +31 more
        Jan 14, 2014

        Healthy Volunteer, Pharmacokinetics of YM178 Trial in Kantou (YM178)

        Completed
        • Healthy Volunteer
        • Pharmacokinetics of YM178
        • Kantou, Japan
          (unnamed)
        Jul 15, 2013

        Chronic Kidney Disease, Secondary Hyperparathyroidism Trial in Charlottesville (Contrast Enhanced Ultrasonography)

        Withdrawn
        • Chronic Kidney Disease
        • Secondary Hyperparathyroidism
        • Contrast Enhanced Ultrasonography
        • Charlottesville, Virginia
          University of Virginia
        May 20, 2014